Business
NeuroPace Announces Strategic CFO Transition
Appoints Patrick F. Williams as Chief Financial Officer Williams Brings a Track Record of Leading Medical Device Public Companies as CFO Rebecca Kuhn Departing Company and Will Remain in Advisory Role MOUNTAIN VIEW, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced the appointment of Mr. Patrick F. Williams as Chief Financial Officer, effective June 20, 2025. Ms. Reb
About this update from Neuropace, Inc.
[{"type":"image","alt":"NeuroPace, Inc.","displaySize":"","headline":null,"caption":"NeuroPace, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":52,"url":"https://media.zenfs.com/en/globenewswire.com/49cad5934d5ea78febfb7e12e9a6509b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/5Q0OXhSfgqHpvUIbwQZadQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTczO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/49cad5934d5ea78febfb7e12e9a6509b","width":300,"height":52}},"lazy":false},{"type":"text","content":"Appoints Patrick F. Williams as Chief Financial Officer","length":55,"tagName":"p"},{"type":"text","content":"Williams Brings a Track Record of Leading Medical Device Public Companies as CFO","length":80,"tagName":"p"},{"type":"text","content":"Rebecca Kuhn Departing Company and Will Remain in Advisory Role ","length":63,"tagName":"p"},{"type":"text","content":"MOUNTAIN VIEW, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced the appointment of Mr. Patrick F. Williams as Chief Financial Officer, effective June 20, 2025. Ms. Rebecca Kuhn has entered into an agreement with the Company to depart from her CFO role and serve in an advisory role to the Company for a twelve-month period.","length":455,"tagName":"p"},{"type":"text","content":"“NeuroPace is pleased to have a financial leader of Patrick’s caliber join the team at a time of such significant opportunity for our RNS System and critical point in our growth trajectory,” said Joel Becker, President and CEO. “He brings a strong track record of success helping medical device companies scale and grow, and his financial leadership will be a tremendous asset as we continue to expand access to the RNS System. His experience across commercial-stage and high-growth organizations will be valuable as we focus on driving long-term value.”","length":554,"tagName":"p"},{"type":"text","content":"Mr. Becker added, “On behalf of the NeuroPace board and employees, I would like to acknowledge and thank Rebecca for her dedication to NeuroPace and for all that she has done for the Company and for our patients over her 25-year tenure. Rebecca has been instrumental in building the foundation of NeuroPace and helping us reach key milestones, and her financial lea...